Enhancement of Bone Repair in Diabetic Rats with Metformin‐Modified Silicified Collagen Scaffolds

Yi‐Rong Wang,Xiao‐Xia Zhang,Xu‐Xu Chen,Xin‐Hua Yin,Ming Yang,Kuo Jiang,Shi‐Chang Liu

DOI: https://doi.org/10.1002/adhm.202401430

IF: 10

2024-08-26

Advanced Healthcare Materials

Abstract:Regenerating bone defects in diabetic patients is a challenging task due to the negative effects of reactive oxygen species (ROS) and impaired autophagy on the bone healing process. To address this issue, a metformin‐modified intra‐fibrous biomimetic silicified collagen scaffold is developed. In vivo and in vitro experiments confirmed that the scaffold promotes bone tissue regeneration in the diabetic microenvironment by improving mitochondrial autophagy and redox homeostasis. Regenerating bone defects in diabetic rats presents a significant challenge due to the detrimental effects of reactive oxygen species and impaired autophagy on bone healing. To address these issues, a metformin‐modified biomimetic silicified collagen scaffold is developed utilizing the principles of biomimetic silicification. In vitro and in vivo experiments demonstrated that the scaffold enhanced bone tissue regeneration within the diabetic microenvironment through the release of dual bio‐factors. Further analysis reveals a potential therapeutic mechanism whereby these dual bio‐factors synergistically promoted osteogenesis in areas of diabetic bone defects by improving mitochondrial autophagy and maintaining redox balance. The present study provides critical insights into the advancement of tissue engineering strategies aimed at bone regeneration in diabetic patients. The study also sheds light on the underlying biological mechanisms.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials